Metagenomic assessment of gut microbial communities and risk of severe COVID-19
Peggy S. Lai(Harvard University), Andrew T. Chan(Harvard University), Kelsey N. Thompson(Broad Institute), Marcia B. Goldberg(Broad Institute), Hui‐Yu Sui(Harvard University), Chun‐Han Lo(Harvard University), Vincent Battista(Massachusetts General Hospital), Ching‐Ying Huang(Harvard University), Amrisha Bhosle(Broad Institute), Jacob Vieira(Harvard University), David A. Drew(Massachusetts General Hospital), Lauren J. McIver(Harvard University), Thomas Kuntz(Klinikum St. Georg), Upasana Das Adhikari(Ragon Institute of MGH, MIT and Harvard), Marina V. Magicheva-Gupta(Massachusetts General Hospital), Lorenzo Berra(Massachusetts General Hospital), Sirus Jesudasen(Harvard University), Alexander Caraballo(Harvard University), Daniel Okin(Harvard University), Jacqueline Woo(Harvard University), Douglas S. Kwon(Ragon Institute of MGH, MIT and Harvard), Long H. Nguyen(Harvard University), Trenton Reinicke(Harvard University), Minsik Kim(Harvard University), Curtis Huttenhower(Harvard University)
Cited by 8
Related Papers
Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
|Nature Biotechnology|2019|24.7k
Metagenomic biomarker discovery and explanation
|Genome biology|2011|16.7k
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
|Genome biology|2012|2.8k